Table 1 Clinicopathologic characteristics of miR-206
From: MicroRNA-206 suppresses gastric cancer cell growth and metastasis
Categories | NO. of patients | Relative levels of miR-206 (mean ± SEM) | P-value |
|---|---|---|---|
Gender | Â | Â | Â |
Male | 21 | 0.49 ± 0.07 | 0.32 |
Female | 14 | 0.40 ± 0.06 |  |
Age (years) | Â | Â | Â |
≥60 | 19 | 0.45 ± 0.05 | 0.93 |
<60 | 16 | 0.46 ± 0.09 |  |
Diameter (cm) | Â | Â | Â |
≥5 | 13 | 0.46 ± 0.09 | 0.90 |
<5 | 22 | 0.45 ± 0.05 |  |
Location | Â | Â | Â |
Middle and proximal third | 23 | 0.47 ± 0.06 | 0.65 |
Distal third | 12 | 0.42 ± 0.07 |  |
Degree of differentiation | Â | Â | Â |
well and moderately | 12 | 0.48 ± 0.07 | 0.70 |
Poorly | 23 | 0.44 ± 0.07 |  |
Local invasion | Â | Â | Â |
T1 + T2 | 10 | 0.65 ± 0.07 | 0.01 |
T3 + T4 | 25 | 0.37 ± 0.05 |  |
Lymph node metastasis | Â | Â | Â |
NO | 14 | 0.57 ± 0.06 | 0.04 |
YES | 21 | 0.38 ± 0.07 |  |
TNM stage | Â | Â | Â |
I + II | 12 | 0.60 ± 0.07 | 0.02 |
III + IV | 23 | 0.38 ± 0.06 |  |